An example is a case where the derivative significantly increases the efficacy of the medical product, thus contributing important benefits to society. This is the approach taken under the new Indian patent law. Article 3(d) of the new Indian Patent Act has pushed subject matter exclusions in the area of medicines further than most other known patent laws.